220 related articles for article (PubMed ID: 12841941)
1. Dosing time dependency of doxorubicin-induced cardiotoxicity and bone marrow toxicity in rats.
To H; Ohdo S; Shin M; Uchimaru H; Yukawa E; Higuchi S; Fujimura A; Kobayashi E
J Pharm Pharmacol; 2003 Jun; 55(6):803-10. PubMed ID: 12841941
[TBL] [Abstract][Full Text] [Related]
2. Cardiotoxicity of doxorubicin/paclitaxel combination in rats: effect of sequence and timing of administration.
Saad SY; Najjar TA; Alashari M
J Biochem Mol Toxicol; 2004; 18(2):78-86. PubMed ID: 15122649
[TBL] [Abstract][Full Text] [Related]
3. Investigation of the influence of modulation of P-glycoprotein by a multiple dosing regimen of tamoxifen on the pharmacokinetics and toxicodynamics of doxorubicin.
Darvari R; Boroujerdi M
Cancer Chemother Pharmacol; 2005 Nov; 56(5):497-509. PubMed ID: 15937726
[TBL] [Abstract][Full Text] [Related]
4. Experimental chronotherapy of mouse mammary adenocarcinoma MA13/C with docetaxel and doxorubicin as single agents and in combination.
Granda TG; Filipski E; D'Attino RM; Vrignaud P; Anjo A; Bissery MC; Lévi F
Cancer Res; 2001 Mar; 61(5):1996-2001. PubMed ID: 11280758
[TBL] [Abstract][Full Text] [Related]
5. New aspects in probucol cardioprotection against doxorubicin-induced cardiotoxicity.
El-Demerdash E; Ali AA; Sayed-Ahmed MM; Osman AM
Cancer Chemother Pharmacol; 2003 Nov; 52(5):411-6. PubMed ID: 12879278
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide and oxidative stress in brain and heart of normal rats treated with doxorubicin: role of aminoguanidine.
Abd El-Gawad HM; El-Sawalhi MM
J Biochem Mol Toxicol; 2004; 18(2):69-77. PubMed ID: 15122648
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic index by combination of adriamycin and docetaxel depends on dosing time in mice.
Tabuchi M; To H; Sakaguchi H; Goto N; Takeuchi A; Higuchi S; Ohdo S
Cancer Res; 2005 Sep; 65(18):8448-54. PubMed ID: 16166324
[TBL] [Abstract][Full Text] [Related]
8. Docetaxel chronopharmacology in mice.
Tampellini M; Filipski E; Liu XH; Lemaigre G; Li XM; Vrignaud P; François E; Bissery MC; Lévi F
Cancer Res; 1998 Sep; 58(17):3896-904. PubMed ID: 9731500
[TBL] [Abstract][Full Text] [Related]
9. Dosing time-dependent variation of bone resorption by cyclosporin A in rats' femurs.
Tsuruoka S; Kaneda T; Maeda A; Ioka T; Fujimura A
Eur J Pharmacol; 2007 Jun; 564(1-3):226-31. PubMed ID: 17362919
[TBL] [Abstract][Full Text] [Related]
10. Circadian time-effect of orally administered loratadine on plasma pharmacokinetics in mice.
Dridi D; Ben-Attia M; Sani M; Djebli N; Sauvage FL; Boughattas NA
Chronobiol Int; 2008 Jul; 25(4):533-47. PubMed ID: 18622814
[TBL] [Abstract][Full Text] [Related]
11. 7-monohydroxyethylrutoside protects against chronic doxorubicin-induced cardiotoxicity when administered only once per week.
van Acker FA; van Acker SA; Kramer K; Haenen GR; Bast A; van der Vijgh WJ
Clin Cancer Res; 2000 Apr; 6(4):1337-41. PubMed ID: 10778960
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of lycopene on adriamycin-induced cardiotoxicity and nephrotoxicity.
Yilmaz S; Atessahin A; Sahna E; Karahan I; Ozer S
Toxicology; 2006 Feb; 218(2-3):164-71. PubMed ID: 16325981
[TBL] [Abstract][Full Text] [Related]
13. Circadian variation of 5-fluorouracil and cis-platinum toxicity in mice.
Shakil A; Hirabayashi N; Toge T
Hiroshima J Med Sci; 1993 Dec; 42(4):147-54. PubMed ID: 8014066
[TBL] [Abstract][Full Text] [Related]
14. Electrocardiographic and biochemical evidence for the cardioprotective effect of vitamin E in doxorubicin-induced acute cardiotoxicity in rats.
Puri A; Maulik SK; Ray R; Bhatnagar V
Eur J Pediatr Surg; 2005 Dec; 15(6):387-91. PubMed ID: 16418954
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of arabic gum against cardiotoxicity induced by doxorubicin in mice: a possible mechanism of protection.
Abd-Allah AR; Al-Majed AA; Mostafa AM; Al-Shabanah OA; Din AG; Nagi MN
J Biochem Mol Toxicol; 2002; 16(5):254-9. PubMed ID: 12439867
[TBL] [Abstract][Full Text] [Related]
16. Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis.
Arola OJ; Saraste A; Pulkki K; Kallajoki M; Parvinen M; Voipio-Pulkki LM
Cancer Res; 2000 Apr; 60(7):1789-92. PubMed ID: 10766158
[TBL] [Abstract][Full Text] [Related]
17. Antarth, a polyherbal preparation protects against the doxorubicin-induced toxicity without compromising its Antineoplastic activity.
Jagetia GC; Reddy TK; Malagi KJ; Nayak BS; Naidu MB; Ravikiran PB; Kamath SU; Shetty PC; Reddy DS
Phytother Res; 2005 Sep; 19(9):772-8. PubMed ID: 16220569
[TBL] [Abstract][Full Text] [Related]
18. Relationship between circadian rhythm of vinorelbine toxicity and efficacy in P388-bearing mice.
Filipski E; Amat S; Lemaigre G; Vincenti M; Breillout F; Lévi FA
J Pharmacol Exp Ther; 1999 Apr; 289(1):231-5. PubMed ID: 10087009
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of caffeic acid phenethyl ester on doxorubicin-induced cardiotoxicity in rats.
Fadillioglu E; Oztas E; Erdogan H; Yagmurca M; Sogut S; Ucar M; Irmak MK
J Appl Toxicol; 2004; 24(1):47-52. PubMed ID: 14745846
[TBL] [Abstract][Full Text] [Related]
20. Modulation by selenium supplementation of lipid peroxidation induced by chronic administration of adriamycin in rats.
Coudray C; Hida H; Boucher F; De Leiris J; Favier A
Nutrition; 1995; 11(5 Suppl):512-6. PubMed ID: 8748211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
